Sainz-Amo, R., Rodero Romero, A., Monreal, E., Chico García, J. L., Fernández Velasco, J. I., Villarrubia, N., . . . Villar, L. M. (2024). Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosis. Frontiers in immunology, 15, 1454474. https://doi.org/10.3389/fimmu.2024.1454474
Chicago Style (17th ed.) CitationSainz-Amo, Raquel, et al. "Effect of Alemtuzumab over SNfL and SGFAP Levels in Multiple Sclerosis." Frontiers in Immunology 15 (2024): 1454474. https://doi.org/10.3389/fimmu.2024.1454474.
MLA (9th ed.) CitationSainz-Amo, Raquel, et al. "Effect of Alemtuzumab over SNfL and SGFAP Levels in Multiple Sclerosis." Frontiers in Immunology, vol. 15, 2024, p. 1454474, https://doi.org/10.3389/fimmu.2024.1454474.
Warning: These citations may not always be 100% accurate.